XLON
PAM
Market cap21mUSD
May 21, Last price
24.00GBP
Name
Creightons PLC
Chart & performance
P/E
6.71
P/S
0.30
EPS
0.04
Div yield, %
2.33%
Shrs. gr., 5y
0.46%
Rev. gr., 5y
2.49%
Revenues
54m
+1.64%
Net income
2m
P
CFO
3m
-51.78%
Dividend
Jul 24, 20250.5 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating both within the United Kingdom and across international markets, Creightons Plc, along with its subsidiaries, specializes in the development, manufacturing, and marketing of a wide array of personal care items and fragrances. Their diverse product portfolio covers categories such as hair care, skin care, bath and body essentials, wellbeing solutions, and male grooming products. In addition to offering their own branded goods, the company provides private label manufacturing for major high street retailers and supermarket chains, and undertakes contract manufacturing for other brand owners. Their extensive brand family includes popular lines like Argan Smooth, Balance Active Formula, Creightons Frizz No More, Feather & Down, and The Curl Company, among many others. Customers also have the convenience of purchasing these products through online platforms. Established in 1954, Creightons Plc maintains its headquarters in Peterborough, UK.
Key people
Martin Stevens
Group Deputy Managing Director, Director · since 2015
Bernard J. M. Johnson
Managing Director, Executive Director · since 2003
Paul John Forster
Director - UK Operations, Director · since 2015
William O. McIlroy
Executive Chairman of the Board, Chief Executive · since 2001
William T. Glencross
Non-Executive Director · since 2006
Nicholas D. J. O'Shea
Company Secretary, Non-Executive Director · since 2001
Headquarters & legal address
1210 LINCOLN ROAD
WERRINGTON
PETERBOROUGH, PTE PE4 6ND
GB
WERRINGTON
PETERBOROUGH, PTE PE4 6ND
GB
Previous name
CREIGHTONS PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||